Recently I ran across the podcast, MEDTECH TALK, and I'll mention a few that caught my attention. (I'm citing a couple from 2023, 2024, but the channel has podcasts right to October 2025).
Find the home page here:
https://medtechmvp.com/media/medtech-talk-podcast
###
Hear about the career path and priorities of Liz Kwo MD MBA, who is now Chief Commercial Officer of Everly Health. July 2024. Find it here. #189.
###
There was a huge valuation bubble in biotech, genomics, etc, during 2020/2021. In this podcast, recorded in July 2023, a panel looks back on the very recent bubble, and predicts the next year. Find it here. #179.
###
Justin Klein, an MD JD who went straight into venture capital, discusses his career and priorities, also from 2023. The focus is "the Medtech Ecosystem," how important it is. There's a substantial section about "reimbursement" as being an opaque unpredictable barrier, a weak link in that ecosystem. (Around minute 20.) Find it here. #182.
###
Valuation bubble. Biodesix (genomic testing) IPO at $250, peak $480, rapid decline over 90% to $30 and under ($6 today). Many diverse genomic companies had 2020/2021 valuation spikes, even if they had no connection to Covid testing or therapies. Invitae rapidly went from $15 to $50 to $15 to 0.
